Access new resources for advanced therapy development, from candidate identification through market authorization.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSThe history of medicine shows that innovations in pharmacotherapy follow close behind developments in cutting edge science and technology platforms. The full sequencing of the human genome, from rough draft in 2000 to full sequence in 2003, and advances in insights on the immune system lead to the better understanding of the aetiology of diseases, brought significant advances in treatment, including the immuno-oncological "checkpoint inhibitors" which have brought huge advances in the treatment of certain cancers. This knowledge is now also being used to develop highly sophisticated gene and cell editing techniques which marks a new era of drug development: the era of Advanced Therapies (ATs).
Over the last decade, Advanced Therapies have emerged as novel treatments for conditions including cancers and rare diseases. Unlike traditional pharmacotherapies, based on small molecules or biopharmaceuticals, ATs are intact, living, human cells or segments of DNA or RNA, which are injected into the patient for therapeutic purpose. Within the human body, such therapies replace, repair or regenerate cells, tissues or organs, restoring or establishing normal function1. According to the European Medicine Agency (EMA), tissue engineered products †, cell therapy, gene therapy are considered as ATs. In this white paper, we will not focus on tissue engineering, and will use the term Advanced Therapies to describe cell and gene therapies only.
Gene therapy involves the use of specific nucleic acid (DNA or RNA) to modify the expression of a patient’s defective gene or to interfere with viral replication. Vectors, either viral or non-viral, are required for the delivery of nucleic acids. Cell therapies use intact living cells, often modified outside the body, and injected into the patient to, for example, specifically target and kill cancerous cells. The source of cells used in cell therapies can be autologous (same individual) or allogeneic (another individual).
Access new resources for advanced therapy development, from candidate identification through market authorization.